Results 41 to 50 of about 40,516 (197)

Economic Evaluation of First-Line Camrelizumab for Advanced Non-small-cell Lung Cancer in China

open access: yesFrontiers in Public Health, 2021
Background: As the first domestic PD-1 antibody approved for lung cancer in China, camrelizumab has exhibited proven effectiveness for non-small-cell lung cancer (NSCLC) patients.
Guiyuan Xiang   +8 more
doaj   +1 more source

Abandoning Eugenics and the QALY

open access: yesINNOVATIONS in pharmacy, 2021
Should decision making in health care, notably in respect of the allocation of resources between individuals and disease states, rest on notions of the burden of disease and denial of care as assessed by societal evaluations or on the extent to which the need of patients and caregivers is fulfilled.
openaire   +4 more sources

Measuring the Benefits of Healthcare: DALYs and QALYs – Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions [PDF]

open access: yesInternational Journal of Health Policy and Management, 2018
Background The measurement of health benefits is a key issue in health economic evaluations. There is very scarce empirical literature exploring the differences of using quality-adjusted life years (QALYs) or disability-adjusted life years (DALYs) as ...
Federico Augustovski   +8 more
doaj   +1 more source

Total QALYs and costs over time.

open access: yes, 2013
Total QALYs and costs over time.
Nicholas Graves (258283)   +8 more
core   +1 more source

Controversies around QALYs [PDF]

open access: yesVnitřní lékařství, 2017
The paper summarizes the criticisms of the QALY concept utilization in health-economic evaluations that has been growing stronger in the last years. Despite of its limitations, the QALY concept has been routinely used in many countries incl. the Czech Republic.
Vladimír, Rogalewicz, Miroslav, Barták
openaire   +2 more sources

QALYs: The Basics

open access: yesКачественная клиническая практика, 2018
.
M. C. Weinstein   +5 more
doaj  

Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancer

open access: yesJournal of the Egyptian National Cancer Institute, 2023
Background The prevalence of head and neck cancer (HNC) is increasing rapidly, and the prognosis is poor in the advance stage. For the patient suffering from advance stage HNC, the improvement in quality of life and decrease mortality remain as the ...
Avinash Khadela   +4 more
doaj   +1 more source

Clinical benefit and cost effectiveness of total knee arthroplasty in the older patient

open access: yesEuropean Journal of Medical Research, 2009
Purpose Total knee arthroplasty (TKA) is an effective, but also cost-intensive health care procedure for the elderly. Furthermore, bearing demographic changes in Western Europe in mind, TKA-associated financial investment for health care insurers will ...
Krummenauer F   +3 more
doaj   +1 more source

Modeling test and treatment strategies for presymptomatic Alzheimer disease. [PDF]

open access: yesPLoS ONE, 2014
OBJECTIVES:In this study, we developed a model of presymptomatic treatment of Alzheimer disease (AD) after a screening diagnostic evaluation and explored the circumstances required for an AD prevention treatment to produce aggregate net population ...
James F Burke   +3 more
doaj   +1 more source

Retaining, and Enhancing, the QALY

open access: yesValue in Health, 2009
quality-of-life impacts, the quality-adjusted life-year (QALY) has beenwidely recognized and endorsed [1–3].The US Panel on Cost-Effectiveness in Health and Medicinerecommended the QALY for “reference case” analyses [2]. TheUK National Institute for Health and Clinical Excellence (NICE)regularly uses QALYs in its technology appraisals [3 ...
Lipscomb, Joseph   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy